ve his view on successfully starting and expanding biotech business, having started nu- merous companies himself. Swedish NEPA Director General Dr. Christina Akcrman will guide us through the Swedish approach to Adaptive Licens- ing — the timely access for patients to new medi- cines still in development. The 20